| Literature DB >> 19124379 |
Laura Carrozzi1, Francesco Pistelli, Giovanni Viegi.
Abstract
Tobacco dependence is a chronic relapsing disease that needs continuous treatment. In combination with behavioural support, pharmacotherapy is a proven key component for supporting smoking cessation. Effective drugs are available and recommended: nicotine replacement therapy (NRT), bupropion and varenicline. Much research into new pharmacological approaches is ongoing, combining 'old' and 'new' drugs and personalizing a pharmacological treatment for a single smoker/patient; other new medications and vaccines are in development. Overall, pharmacotherapy seems to have efficacy and cost-effectiveness in real life, thus physicians should become familiar with these medicines. Further efforts should be aimed at optimizing treatment management and increasing smoking cessation rates in the general population.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19124379 DOI: 10.1177/1753465808096136
Source DB: PubMed Journal: Ther Adv Respir Dis ISSN: 1753-4658 Impact factor: 4.031